Literature DB >> 30173314

Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.

Admassu N Lamu1, Jan Abel Olsen2,3.   

Abstract

PURPOSE: The purpose of the study was to compare alternative statistical techniques to find the best approach for converting QLQ-C30 scores onto EQ-5D-5L and SF-6D utilities, and to estimate the mapping algorithms that best predict these health state utilities.
METHODS: 772 cancer patients described their health along the cancer-specific instrument (QLQ-C30) and two generic preference-based instruments (EQ-5D-5L and SF-6D). Seven alternative regression models were applied: ordinary least squares, generalized linear model, extended estimating equations (EEE), fractional regression model, beta binomial (BB) regression, logistic quantile regression and censored least absolute deviation. Normalized mean absolute error (NMAE), normalized root mean square error (NRMSE), r-squared (r2) and concordance correlation coefficient (CCC) were used as model performance criteria. Cross-validation was conducted by randomly splitting internal dataset into two equally sized groups to test the generalizability of each model.
RESULTS: In predicting EQ-5D-5L utilities, the BB regression performed best. It gave better predictive accuracy in terms of all criteria in the full sample, as well as in the validation sample. In predicting SF-6D, the EEE performed best. It outperformed in all criteria: NRMSE = 0.1004, NMAE = 0.0798, CCC = 0.842 and r2 = 72.7% in the full sample, and NRMSE = 0.1037, NMAE = 0.0821, CCC = 0.8345 and r2 = 71.4% in cross-validation.
CONCLUSIONS: When only QLQ-C30 data are available, mapping provides an alternative approach to obtain health state utility data for use in cost-effectiveness analyses. Among seven alternative regression models, the BB and the EEE gave the most accurate predictions for EQ-5D-5L and SF-6D, respectively.

Entities:  

Keywords:  EQ-5D-5L; Mapping; QALYs; QLQ-C30; Regression models; SF-6D

Mesh:

Year:  2018        PMID: 30173314     DOI: 10.1007/s11136-018-1981-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  38 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D.

Authors:  Matthijs M Versteegh; Annemieke Leunis; Jolanda J Luime; Mike Boggild; Carin A Uyl-de Groot; Elly A Stolk
Journal:  Med Decis Making       Date:  2011-11-22       Impact factor: 2.583

3.  Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.

Authors:  Ralph Crott; Andrew Briggs
Journal:  Eur J Health Econ       Date:  2010-05-16

4.  Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients.

Authors:  Eun-ju Kim; Su-Kyoung Ko; Hye-Young Kang
Journal:  Qual Life Res       Date:  2011-10-20       Impact factor: 4.147

5.  Aiming High--Changing the Trajectory for Cancer.

Authors:  Douglas R Lowy; Francis S Collins
Journal:  N Engl J Med       Date:  2016-04-04       Impact factor: 91.245

6.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).

Authors:  Billingsley Kaambwa; Gang Chen; Julie Ratcliffe; Angelo Iezzi; Aimee Maxwell; Jeff Richardson
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

7.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

8.  In search of a common currency: A comparison of seven EQ-5D-5L value sets.

Authors:  Jan Abel Olsen; Admassu N Lamu; John Cairns
Journal:  Health Econ       Date:  2017-10-24       Impact factor: 3.046

9.  Cost utility of prenatal diagnosis and the risk-based threshold.

Authors:  Ryan A Harris; A Eugene Washington; Robert F Nease; Miriam Kuppermann
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

10.  Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data.

Authors:  Lynda McKenzie; Marjon van der Pol
Journal:  Value Health       Date:  2008-07-11       Impact factor: 5.725

View more
  5 in total

1.  Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia.

Authors:  Richard Huan Xu; Dong Dong; Nan Luo; Eliza Lai-Yi Wong; Renchi Yang; Junshuai Liu; Huiqin Yuan; Shuyang Zhang
Journal:  Qual Life Res       Date:  2021-11-30       Impact factor: 4.147

2.  Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.

Authors:  Aurelie Meunier; Alexandra Soare; Helene Chevrou-Severac; Karl-Johan Myren; Tatsunori Murata; Louise Longworth
Journal:  Appl Health Econ Health Policy       Date:  2021-09-23       Impact factor: 3.686

3.  Does linear equating improve prediction in mapping? Crosswalking MacNew onto EQ-5D-5L value sets.

Authors:  Admassu N Lamu
Journal:  Eur J Health Econ       Date:  2020-04-16

4.  Predictive analysis of the number of human brucellosis cases in Xinjiang, China.

Authors:  Yanling Zheng; Liping Zhang; Chunxia Wang; Kai Wang; Gang Guo; Xueliang Zhang; Jing Wang
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

5.  Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer.

Authors:  Yasuhiro Hagiwara; Takeru Shiroiwa; Naruto Taira; Takuya Kawahara; Keiko Konomura; Shinichi Noto; Takashi Fukuda; Kojiro Shimozuma
Journal:  Health Qual Life Outcomes       Date:  2020-11-03       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.